• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像放射组学特征作为预测局部晚期直肠癌患者病情的潜在生物标志物

MRI Radiomics Signature as a Potential Biomarker for Predicting Status in Locally Advanced Rectal Cancer Patients.

作者信息

Zhang ZhiYuan, Shen LiJun, Wang Yan, Wang Jiazhou, Zhang Hui, Xia Fan, Wan JueFeng, Zhang Zhen

机构信息

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Front Oncol. 2021 May 7;11:614052. doi: 10.3389/fonc.2021.614052. eCollection 2021.

DOI:10.3389/fonc.2021.614052
PMID:34026605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8138318/
Abstract

BACKGROUND AND PURPOSE

Locally advanced rectal cancer (LARC) is a heterogeneous disease with little information about status and image features. The purpose of this study was to analyze the association between T2 magnetic resonance imaging (MRI) radiomics features and status in LARC patients.

MATERIAL AND METHODS

Eighty-three patients with status information and T2 MRI images between 2012.05 and 2019.09 were included. Least absolute shrinkage and selection operator (LASSO) regression was performed to assess the associations between features and gene status. The patients were divided 7:3 into training and validation sets. The C-index and the average area under the receiver operator characteristic curve (AUC) were used for performance evaluation.

RESULTS

The clinical characteristics of 83 patients in the mutant and wild-type cohorts were balanced. Forty-two (50.6%) patients had mutations, and 41 (49.4%) patients had wild-type . A total of 253 radiomics features were extracted from the T2-MRI images of LARC patients. One radiomic feature named X.LL_scaled_std, a standard deviation value of scaled wavelet-transformed low-pass channel filter, was selected from 253 features (=0.019). The radiomics-based C-index values were 0.801 (95% CI: 0.772-0.830) and 0.703 (95% CI: 0.620-0.786) in the training and validation sets, respectively.

CONCLUSION

Radiomics features could differentiate status in LARC patients based on T2-MRI images. Further validation in a larger dataset is necessary in the future.

摘要

背景与目的

局部进展期直肠癌(LARC)是一种异质性疾病,关于其状态和影像特征的信息较少。本研究旨在分析LARC患者T2加权磁共振成像(MRI)影像组学特征与状态之间的关联。

材料与方法

纳入2012年5月至2019年9月间有状态信息且有T2加权MRI图像的83例患者。采用最小绝对收缩和选择算子(LASSO)回归评估特征与基因状态之间的关联。将患者按7:3比例分为训练集和验证集。采用C指数和受试者操作特征曲线(AUC)下的平均面积进行性能评估。

结果

突变型和野生型队列中83例患者的临床特征均衡。42例(50.6%)患者有突变,41例(49.4%)患者为野生型。从LARC患者的T2加权MRI图像中总共提取了253个影像组学特征。从253个特征中(=0.019)选择了一个名为X.LL_scaled_std的影像组学特征,即小波变换低通通道滤波器的缩放标准差。基于影像组学的训练集和验证集C指数值分别为0.801(95%CI:0.772 - 0.830)和0.703(95%CI:0.620 - 0.786)。

结论

影像组学特征可基于T2加权MRI图像区分LARC患者的状态。未来有必要在更大的数据集中进行进一步验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/a4f188592cbb/fonc-11-614052-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/62817f61c564/fonc-11-614052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/d77aceec27cb/fonc-11-614052-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/c0187fd3dc04/fonc-11-614052-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/a4f188592cbb/fonc-11-614052-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/62817f61c564/fonc-11-614052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/d77aceec27cb/fonc-11-614052-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/c0187fd3dc04/fonc-11-614052-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440b/8138318/a4f188592cbb/fonc-11-614052-g004.jpg

相似文献

1
MRI Radiomics Signature as a Potential Biomarker for Predicting Status in Locally Advanced Rectal Cancer Patients.磁共振成像放射组学特征作为预测局部晚期直肠癌患者病情的潜在生物标志物
Front Oncol. 2021 May 7;11:614052. doi: 10.3389/fonc.2021.614052. eCollection 2021.
2
KRAS status predicted by pretreatment MRI radiomics was associated with lung metastasis in locally advanced rectal cancer patients.术前 MRI 放射组学预测的 KRAS 状态与局部晚期直肠癌患者的肺转移相关。
BMC Med Imaging. 2023 Dec 12;23(1):210. doi: 10.1186/s12880-023-01173-5.
3
Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.多参数 MRI 的放射组学分析预测局部晚期直肠癌新辅助放化疗的病理完全缓解。
Eur Radiol. 2019 Mar;29(3):1211-1220. doi: 10.1007/s00330-018-5683-9. Epub 2018 Aug 20.
4
Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer.基于 MRI 的放射组学特征的建立和验证用于预测直肠癌 KRAS 突变。
Eur Radiol. 2020 Apr;30(4):1948-1958. doi: 10.1007/s00330-019-06572-3. Epub 2020 Jan 15.
5
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study.基于磁共振成像的放射组学预测局部晚期直肠癌新辅助放化疗疗效:一项多中心研究
Clin Transl Radiat Oncol. 2022 Nov 17;38:175-182. doi: 10.1016/j.ctro.2022.11.009. eCollection 2023 Jan.
6
Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study.基于治疗前T2加权成像的影像组学特征预测局部晚期直肠癌对新辅助放化疗无反应的初步研究
Cancers (Basel). 2020 Jul 14;12(7):1894. doi: 10.3390/cancers12071894.
7
Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.基于放射组学的直肠癌早期退缩指数预测治疗反应的多中心研究:0.35T MRI 引导放疗研究。
Radiol Med. 2024 Apr;129(4):615-622. doi: 10.1007/s11547-024-01761-7. Epub 2024 Mar 21.
8
Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.基于放射组学的局部晚期直肠癌新辅助治疗无反应的预测。
Ann Surg Oncol. 2019 Jun;26(6):1676-1684. doi: 10.1245/s10434-019-07300-3. Epub 2019 Mar 18.
9
Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.基于 MRI 的放射组学比较新辅助放疗前后预测局部晚期直肠癌的病理完全缓解。
Cancer Med. 2019 Dec;8(17):7244-7252. doi: 10.1002/cam4.2636. Epub 2019 Oct 22.
10
Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.多模态放射组学模型预测局部晚期直肠癌新辅助化疗的治疗反应。
World J Gastroenterol. 2020 May 21;26(19):2388-2402. doi: 10.3748/wjg.v26.i19.2388.

引用本文的文献

1
Performance of Machine Learning in Diagnosing KRAS (Kirsten Rat Sarcoma) Mutations in Colorectal Cancer: Systematic Review and Meta-Analysis.机器学习在诊断结直肠癌KRAS( Kirsten大鼠肉瘤)突变中的性能:系统评价和荟萃分析
J Med Internet Res. 2025 Jul 18;27:e73528. doi: 10.2196/73528.
2
MRI Delta Radiomics to Track Early Changes in Tumor Following Radiation: Application in Glioblastoma Mouse Model.MRI 影像组学增量分析用于追踪放疗后肿瘤的早期变化:在胶质母细胞瘤小鼠模型中的应用
Biomedicines. 2025 Mar 28;13(4):815. doi: 10.3390/biomedicines13040815.
3
Image Analysis as tool for Predicting Colorectal Cancer Molecular Alterations: A Scoping Review.

本文引用的文献

1
Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis.KRAS突变状态在结直肠癌患者中的预后价值:一项基于人群的竞争风险分析。
PeerJ. 2020 Jun 1;8:e9149. doi: 10.7717/peerj.9149. eCollection 2020.
2
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.影像生物标志物标准化倡议:高通量基于影像表型的标准化定量放射组学。
Radiology. 2020 May;295(2):328-338. doi: 10.1148/radiol.2020191145. Epub 2020 Mar 10.
3
Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer.
图像分析作为预测结直肠癌分子改变的工具:一项范围综述
Mol Imaging Radionucl Ther. 2025 Feb 7;34(1):10-25. doi: 10.4274/mirt.galenos.2024.86402.
4
Comparison of Intratumoral and Peritumoral Deep Learning, Radiomics, and Fusion Models for Predicting KRAS Gene Mutations in Rectal Cancer Based on Endorectal Ultrasound Imaging.基于直肠内超声成像的深度学习、影像组学及融合模型在预测直肠癌KRAS基因突变中的瘤内与瘤周比较
Ann Surg Oncol. 2025 Apr;32(4):3019-3030. doi: 10.1245/s10434-024-16697-5. Epub 2024 Dec 17.
5
The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer.基于MRI的预测和预后生物标志物在直肠癌全新辅助治疗时代的作用
Cancers (Basel). 2024 Sep 9;16(17):3111. doi: 10.3390/cancers16173111.
6
Assessment of prognostic indicators and KRAS mutations in rectal cancer using a fractional-order calculus MR diffusion model: whole tumor histogram analysis.使用分数阶微积分磁共振扩散模型评估直肠癌的预后指标和KRAS突变:全肿瘤直方图分析
Abdom Radiol (NY). 2025 Feb;50(2):569-578. doi: 10.1007/s00261-024-04523-1. Epub 2024 Aug 16.
7
Radiogenomics: Contemporary Applications in the Management of Rectal Cancer.放射基因组学:在直肠癌管理中的当代应用
Cancers (Basel). 2023 Dec 12;15(24):5816. doi: 10.3390/cancers15245816.
8
KRAS status predicted by pretreatment MRI radiomics was associated with lung metastasis in locally advanced rectal cancer patients.术前 MRI 放射组学预测的 KRAS 状态与局部晚期直肠癌患者的肺转移相关。
BMC Med Imaging. 2023 Dec 12;23(1):210. doi: 10.1186/s12880-023-01173-5.
9
Investigating the Feasibility of Predicting KRAS Status, Tumor Staging, and Extramural Venous Invasion in Colorectal Cancer Using Inter-Platform Magnetic Resonance Imaging Radiomic Features.利用跨平台磁共振成像放射组学特征研究预测结直肠癌KRAS状态、肿瘤分期和壁外静脉侵犯的可行性。
Diagnostics (Basel). 2023 Nov 27;13(23):3541. doi: 10.3390/diagnostics13233541.
10
Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review.人工智能与放射组学在直肠癌磁共振成像中的应用综述
Explor Target Antitumor Ther. 2023;4(3):406-421. doi: 10.37349/etat.2023.00142. Epub 2023 Jun 30.
基于 MRI 的放射组学特征的建立和验证用于预测直肠癌 KRAS 突变。
Eur Radiol. 2020 Apr;30(4):1948-1958. doi: 10.1007/s00330-019-06572-3. Epub 2020 Jan 15.
4
Characterizing MRI features of rectal cancers with different KRAS status.分析不同 KRAS 状态的直肠癌的 MRI 特征。
BMC Cancer. 2019 Nov 14;19(1):1111. doi: 10.1186/s12885-019-6341-6.
5
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.非小细胞肺癌组织学分型与突变状态相关的葡萄糖和谷氨酰胺代谢。
Thorac Cancer. 2019 Dec;10(12):2289-2299. doi: 10.1111/1759-7714.13226. Epub 2019 Oct 30.
6
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies.辅助治疗后疾病复发的微卫星不稳定和/或错配修复缺陷 III 期结肠癌患者的预后:来自七个研究的 ACCENT 汇总分析的结果。
Ann Oncol. 2019 Sep 1;30(9):1466-1471. doi: 10.1093/annonc/mdz208.
7
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.在一个大型局部晚期直肠癌患者前瞻性系列中分析 KRAS、NRAS、BRAF、PIK3CA 和 TP53 突变。
Int J Cancer. 2020 Jan 1;146(1):94-102. doi: 10.1002/ijc.32507. Epub 2019 Jul 5.
8
Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer.磁共振纹理分析鉴别直肠癌 KRAS 突变状态
Cancer Res Treat. 2020 Jan;52(1):51-59. doi: 10.4143/crt.2019.050. Epub 2019 May 7.
9
SUVmax and metabolic tumor volume: surrogate image biomarkers of KRAS mutation status in colorectal cancer.最大标准摄取值(SUVmax)与代谢肿瘤体积:结直肠癌中KRAS突变状态的替代影像生物标志物
Onco Targets Ther. 2019 Mar 21;12:2115-2121. doi: 10.2147/OTT.S196725. eCollection 2019.
10
Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.18F-FDG PET/CT 预测结直肠癌患者 KRAS 突变的诊断性能:系统评价和荟萃分析。
Abdom Radiol (NY). 2019 May;44(5):1703-1711. doi: 10.1007/s00261-018-01891-3.